PK calculations Flashcards

1
Q

Digoxin mechanism of action and therapeutic range?

A

Increase CF, Decrease AV conduction (POSITIVE INOTROPE). Increases amount of calcium in cardiomyocytes.
target = 0.8-2microgram/L
toxicity > 2.5microgram/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Theophylline Target

Clearance increased in?

A

10-20mg/L

Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Theophylline Target neonates

A

50% metabolised to caffeine. 5-10microgram/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Gentamicin info, side effects, therapeutic ranges

A

aminoglycoside. Low therapeutic index causing nephro + ototoxicity
Target peak = 5-8mg/L multiple or 20mg/L for once daily
Target trough < 1mg/L
PEAK =/ measured 1 hour post IV/IM should not exceed 12mg/L
TROUGH = immediately before dose should not exceed 2mg/L
If trough too high - increase dose interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lithium, how it works, target concentrations. Signs of toxicity

A

Substitute for sodium or potassium in the CNS
0.4-1mmol/L optimum prophylaxis
0.8-1.2mmol/L for acute mania
TOXICITY > 1.5mmol/L = N+D+V, CNS deficits, tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lithium model , concentration measurements and drug interactions

A

2-compartment model. Before morning dose and ideally 12 hours after last evening dose. Steady state in 3-5 days.
ACE increase Lithium levels, thiazide increase levels through impact on sodium levels. Theophylline and caffeine decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Designing a Lithium dose regimen

A
  1. Estimate CrCL (ml/min)
  2. Estimate Lithium Clearance (L/h)
  3. Choose Lithium concentration within the range (e.g. 5mmol/L)
  4. DR (mg/h) = CL x Cssav / F.s.m
  5. Daily dose (mg) = CL x 0.5 (target conc) x 24 / F.s.m
    s and m convert dose of lithium salt from mg to dose of Li in mmol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Checking a Lithium dose regimen

A
  1. Estimate CrCL (ml/min)
  2. Estimate Lithium Clearance (L/h)
  3. Predict average SS conc and compare with target
    Predicted = DR/CL = F.s.m.Dose (mg)/Lithium Clearance x 24
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Factors to consider when interpreting serum concentration

A

Poor control, toxicity
Is the time the sample is taken a valid comparison with target range?
Is the sample likely to represent steady state?
Has the patient adhered to regimen?
Beware of on admission samples
Is the result consistent with prescribed/reported dosage regimens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Designing a gentamicin dose regimen

A
  1. Target peak>12mg/L
    trough < 0.5mg/L
  2. How often?
    dosage interval must be 4-5 intervals, choose practical 24, 36, 48 hourly
  3. Dose (mg) = Target C (mg/L) x V (L)
  4. Confirm safety. Predict SS peak and trough then check these are within the target range.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Designing a vancomycin dose regimen

A
1. Loading dose
Target Cpeak = 20mg/L
Dose = Ctarget x V (round to nearest 250mg)
2. Maintenance Dose
Css target = 20mg/L
DR (mg/L) = Ctarget x CL (L/h)
Daily dose (mg/day) = Ctarget x CL (L/h) x 24
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

vancomycin how to administer:

  1. Continuous infusion
  2. Intermittent infusion
A
  1. daily dose then either continuous or 2x 12hr infusions
  2. Daily dose into 1,2 or 3. Aim to maintain trough >10mg/L.
    * EACH DOSE INFUSED AT 500mg/hr and NO FASTER*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

vancomycin toxicity

A

> 20mg/L
7 days duration
rate >500mg/hr - red man syndrome caused by histamine release. Occurs 4-10mins after start of infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2 compartment model

A

e.g. digoxin/lithium
Compartment 1 - drug first diffuses into blood, liver, kidney
Compartment 2 - poorly perfused tissues
Distribution into 2nd compartment continues until the free conc in the 2nd compartment is equal to the free conc in the peripheral compartment.
diffuses back into compartment 1 for elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

considerations for 2 compartment model when measuring concentrations

A

High C before distribution misleading (not actually dangerous). After IV digoxin, clinicians wait 4-6 hours before taking serum concentration.
Plasma samples obtained less than 6 hours after oral digoxin or 12 hours after oral IR lithium are of questionable value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phenytoin - target range and main characteristic

A

5-20mg/L
Non-linear elimination. Rate of metabolism increases as concentration increases. At high conc Vmax is reached (max rate of metabolism)
Rate of metabolism = Vmax.C/Km+C (Km=conc at half Vmax)

17
Q

Concentration

A

linear pharmacokinetic elimination.

Conc>Km - nonlinear

18
Q

Loading dose Phenytoin (no drug present)

A

LD = Target C x V/F.s.m

target C top of range = 20-25 mg/L

19
Q

Loading dose Phenytoin (drug present)

A

LD = (Target C- Measured C) x V/F.s.m

20
Q

Maintenance Dose

A

MD = Target C (lower 8-12mg/L) x V/F.s.m

21
Q

When should lithium conc be measured

A

days 4-7 then weekly till stable for 4 weeks (increases serotonin, NE, glutamate)

22
Q

Digoxin Toxicity, causes, symptoms, range

A

GI - N+V+D, Visual Disturbances, headache, fatigue
Cardiac - AV block. >2.5um/L
Causes. Potentiated by hypokalaemia (diuretics), hypothyroidism. PGP substrate - quinidine inhibits PGP increasing digoxin conc
Interactions - CYP3A4 Inhibitors increase digoxin conc (amiodarone, verapamil, macrolides, spironolactone)
Inducers decrease dig conc (rifampicin, St John’s Wort)

23
Q

Digoxin V of distribution

A

Use actual up to 20% above ideal body weight in obesity. Reduced in renal impairment

24
Q

Designing a digoxin dosage regimen

A

Oral LD = Dose (ug) = Ctarget (ug/L) x V/F.s

Oral MD = Cav target x CL x dosage interval(h)/F.s

25
Q

When is steady state achieved?

A

After 5 half lives (t1/2 = 0.693/k)

26
Q

Michaelis-Menten given in exam

A

DR=Vmax.C/Km+C

27
Q

Phenytoin (DR=Vmax.C/Km+C) rearranged for Css av

A

Css av = Km.DR/Vmax - DR

28
Q

t1/2 Phenytoin

A

t1/2 = 0.693 x V (Km+Css) /Vmax

29
Q

what happens to Fu of phenytoin if albumin is low?

A

Fu increases. Bound and total decreases. This leads to misinterpretation of phenytoin calculations

30
Q

C phenytoin corrected

A

Ccorrected = Cmeasured / ((0.9xalbumin/42) +0.1)

31
Q

Phenytoin Cl

A

CL=Vmax/Km+Css